404 related articles for article (PubMed ID: 23932729)
1. Clinical and molecular mechanisms favoring cancer initiation and progression in diabetic patients.
Sciacca L; Vigneri R; Tumminia A; Frasca F; Squatrito S; Frittitta L; Vigneri P
Nutr Metab Cardiovasc Dis; 2013 Sep; 23(9):808-15. PubMed ID: 23932729
[TBL] [Abstract][Full Text] [Related]
2. Type 2 diabetes and cancer: what is the connection?
Cannata D; Fierz Y; Vijayakumar A; LeRoith D
Mt Sinai J Med; 2010; 77(2):197-213. PubMed ID: 20309918
[TBL] [Abstract][Full Text] [Related]
3. [Diabetes and cancer risk: oncologic considerations].
Rosta A
Orv Hetil; 2011 Jul; 152(29):1144-55. PubMed ID: 21712179
[TBL] [Abstract][Full Text] [Related]
4. [Correlations of insulin resistance and neoplasms].
Suba Z; Ujpál M
Magy Onkol; 2006; 50(2):127-35. PubMed ID: 16888676
[TBL] [Abstract][Full Text] [Related]
5. Diabetes and cancer: a 2013 synopsis.
Buysschaert M; Sadikot S
Diabetes Metab Syndr; 2013; 7(4):247-50. PubMed ID: 24290094
[TBL] [Abstract][Full Text] [Related]
6. Diabetes, antihyperglycemic medications and cancer risk: smoke or fire?
Gallagher EJ; LeRoith D
Curr Opin Endocrinol Diabetes Obes; 2013 Oct; 20(5):485-94. PubMed ID: 23974779
[TBL] [Abstract][Full Text] [Related]
7. The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas.
Giovannucci E; Michaud D
Gastroenterology; 2007 May; 132(6):2208-25. PubMed ID: 17498513
[TBL] [Abstract][Full Text] [Related]
8. Hypoglycemic pharmacological treatment of type 2 diabetes: targeting the endothelium.
Nathanson D; Nyström T
Mol Cell Endocrinol; 2009 Jan; 297(1-2):112-26. PubMed ID: 19038307
[TBL] [Abstract][Full Text] [Related]
9. Diabetes, insulin, and risk of cancer.
Schiel R; Beltschikow W; Steiner T; Stein G
Methods Find Exp Clin Pharmacol; 2006 Apr; 28(3):169-75. PubMed ID: 16810343
[TBL] [Abstract][Full Text] [Related]
10. [Role of obesity in colorectal carcinogenesis].
Hagymási K; Tulassay Z
Orv Hetil; 2007 Dec; 148(51):2411-6. PubMed ID: 18055394
[TBL] [Abstract][Full Text] [Related]
11. [Obesity, insulin resistance and type 2 diabetes: risk factors for breast cancer].
Scheen AJ; Beck E; De Flines J; Rorive M
Rev Med Liege; 2011; 66(5-6):238-44. PubMed ID: 21826954
[TBL] [Abstract][Full Text] [Related]
12. Energy balance, physical activity, and cancer risk.
Fair AM; Montgomery K
Methods Mol Biol; 2009; 472():57-88. PubMed ID: 19107429
[TBL] [Abstract][Full Text] [Related]
13. Diabetes mellitus type 2 - an independent risk factor for cancer?
Grote VA; Becker S; Kaaks R
Exp Clin Endocrinol Diabetes; 2010 Jan; 118(1):4-8. PubMed ID: 20127570
[TBL] [Abstract][Full Text] [Related]
14. Experimental evidence for the use of CCR2 antagonists in the treatment of type 2 diabetes.
Sullivan TJ; Miao Z; Zhao BN; Ertl LS; Wang Y; Krasinski A; Walters MJ; Powers JP; Dairaghi DJ; Baumgart T; Seitz LC; Berahovich RD; Schall TJ; Jaen JC
Metabolism; 2013 Nov; 62(11):1623-32. PubMed ID: 23953944
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms linking diet and colorectal cancer: the possible role of insulin resistance.
Bruce WR; Wolever TM; Giacca A
Nutr Cancer; 2000; 37(1):19-26. PubMed ID: 10965515
[TBL] [Abstract][Full Text] [Related]
16. Insulin use is not significantly predictive for prostate cancer mortality in diabetic patients: a 12-year follow-up study.
Tseng CH
BJU Int; 2012 Sep; 110(5):668-73. PubMed ID: 22300458
[TBL] [Abstract][Full Text] [Related]
17. Adiposity, type 2 diabetes and the metabolic syndrome in breast cancer.
Vona-Davis L; Howard-McNatt M; Rose DP
Obes Rev; 2007 Sep; 8(5):395-408. PubMed ID: 17716297
[TBL] [Abstract][Full Text] [Related]
18. The cellular and molecular mechanisms by which insulin influences breast cancer risk and progression.
Rose DP; Vona-Davis L
Endocr Relat Cancer; 2012 Dec; 19(6):R225-41. PubMed ID: 22936542
[TBL] [Abstract][Full Text] [Related]
19. Diabetes and cancer.
Vigneri P; Frasca F; Sciacca L; Pandini G; Vigneri R
Endocr Relat Cancer; 2009 Dec; 16(4):1103-23. PubMed ID: 19620249
[TBL] [Abstract][Full Text] [Related]
20. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
Resmini E; Minuto F; Colao A; Ferone D
Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
